Thierry André, MD

Articles by Thierry André, MD

Thierry André, MDColorectal Cancer | January 31, 2025
Dr. André elaborates on the efficacy and safety profiles of both treatments and their influence on current therapies.
View More
Thierry André, MDColorectal Cancer | March 13, 2025
Nivolumab plus ipilimumab showed significant improvement in progression-free survival in patients in the first line setting.